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New insights into fetal 
mammary gland morphogenesis: 
differential effects of natural and 
environmental estrogens
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An increased breast cancer risk during adulthood has been linked to estrogen exposure during fetal 
life. However, the impossibility of removing estrogens from the feto-maternal unit has hindered the 
testing of estrogen’s direct effect on mammary gland organogenesis. To overcome this limitation, we 
developed an ex vivo culture method of the mammary gland where the direct action of estrogens can 
be tested during embryonic days (E)14 to 19. Mouse mammary buds dissected at E14 and cultured 
for 5 days showed that estrogens directly altered fetal mammary gland development. Exposure to 
0.1 pM, 10 pM, and 1 nM 17 β-estradiol (E2) resulted in monotonic inhibition of mammary buds ductal 
growth. In contrast, Bisphenol-A (BPA) elicited a non-monotonic response. At environmentally relevant 
doses (1 nM), BPA significantly increased ductal growth, as previously observed in vivo, while 1 μM 
BPA significantly inhibited ductal growth. Ductal branching followed the same pattern. This effect of 
BPA was blocked by Fulvestrant, a full estrogen antagonist, while the effect of estradiol was not. This 
method may be used to study the hormonal regulation of mammary gland development, and to test 
newly synthesized chemicals that are released into the environment without proper assessment of their 
hormonal action on critical targets like the mammary gland.
Fetal exposure to endogenous and synthetic estrogens has been linked to an increased risk of developing breast 
cancer1–5, yet the pathways by which estrogens alter fetal mammary gland development remain to be elucidated. 
In rodents, alpha-fetoprotein (AFP) present in amniotic fluid and fetal serum binds to ovarian estrogens decreas-
ing their bioavailability thereby protecting the fetus from harmful levels of estrogen6. Thus, the presence of AFP 
hinders the study of direct effects of estrogen on the mouse fetal mammary gland. Notwithstanding, environmen-
tal estrogens such as BPA increased the propensity of developing mammary cancer7–12. The xenoestrogen BPA is 
widely employed in the manufacture of polycarbonate plastics and epoxy resins and it is present in products used 
on a daily basis13 such as thermal paper14,15. BPA has been detected in more than 90% of urine from samples rep-
resentative of the US population suggesting that human exposure to the chemical is widespread16. BPA has also 
been detected in the blood of adults, and in the placenta, umbilical cord and fetal plasma indicating that the fetus 
is exposed to BPA in the womb. Perinatal exposure to BPA has been linked to the development of a plethora of 
metabolic17,18, behavioral19–21, and reproductive22 disorders. Fetal exposure to BPA alters the overall organization 
of the mouse mammary gland, impairs mammary gland development causing functional lactational changes23 
and increases the risk of developing mammary cancer during adulthood24–26. At E18, the mammary glands of 
fetuses exposed to low dose of BPA showed accelerated adipogenesis, decreased expression of tenascin C and ver-
sican27, altered collagen deposition in the stroma, accelerated ductal growth and delayed lumen formation28. BPA 
exposure induced similar changes in the fetal mammary gland of non-human primates29. However animal mod-
els cannot reveal whether this BPA effect is mediated directly through the estrogen receptors (ER) present in the 
fetal mammary gland stroma27 and/or indirectly through the hypothalamic–pituitary–gonadal axis (HPOA)30.
The newly developed ex vivo culture method described herein makes it possible to examine the direct action 
of estrogens and estrogen-mimics on fetal mammary gland development. Previously we described a methodology 
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that ensures reproducibility31,32; however, this culture technique is not suitable for the study of estrogen action 
since it uses culture medium containing serum and thus endogenous estrogens. We have now modified that cul-
ture method by using estrogen-depleted serum. This modification enabled us to perform a quantitative analysis 
of the consequences of exposure to estrogenic compounds based on morphometric parameters.
Results
Cultured fetal mammary glands of CD-1 mice develop in estrogen-free conditions and show 
similar structures as those observed in vivo. We first compared the development of the fetal mam-
mary ductal system in hormone-free conditions [10% charcoal dextran-stripped fetal bovine serum (CDFBS)] 
to that obtained when the mammary glands were cultured in medium containing 10% FBS. Ductal area and 
number of ductal tips were measured in carmine-stained whole-mounts of the cultured mammary glands 
(Fig. 1). Ductal area was larger in 10% CDFBS than in 10% FBS, while the number of ductal tips, a measure of 
complexity, was higher in glands cultured in 10% FBS compared to 10% CDFBS, but these differences did not 
reach statistical significance. Ductal area in 10% CDFBS was comparable to that observed in E18 mammary 
glands developed in situ and there was a significantly higher number of ductal tips in the former than in the 
latter (P = 0.02). In contrast, the ductal area in 10% FBS was significantly smaller than the one in the E18 devel-
opmental stage (P < 0.0005) (Fig. 1). These findings suggest that ductal growth is inhibited to some extent by 
the estrogens present in FBS, which are removed by charcoal dextran-stripping. The number of ductal tips of 
the cultured mammary glands falls between that found in fetuses at E18 and 19. In order to further confirm 
that the stage of development in culture resembles the stage in situ, we analyzed the epithelial compartment for 
lumen formation and markers of mammary epithelial differentiation. After 5 days in culture, lumen formation, 
a feature observed in vivo at E1828,33, was also observed when using confocal microscopy (Fig. 2A,B and C). 
The mammary epithelial cells in the explant expressed cytokeratin (K) 14 and K18 (Fig. 2D), as observed 
in vivo at E18.534.
Fetal mammary glands cultured ex vivo respond to hormonally-active chemicals: E2 inhibits 
ductal development while BPA increases it at low doses and inhibits it at high doses. The cul-
tured mammary glands were exposed to a range of E2 (Fig. 3) and BPA (Fig. 4) concentrations for a period of 5 
days. Cultures were harvested, whole-mounted and stained with carmine-alum and assessed by morphometric 
analysis. Epithelial growth was significantly diminished in mammary buds exposed to 0.1 pM, 10 pM, and 1 nM 
E2 compared to control (P = 0.005, < 0.0005 and = 0.002, respectively); while 1 fM E2 had no effect (Fig. 3E). 
Exposure of the explants to 1 nM BPA significantly increased ductal growth (P = 0.032) while 1 μ M BPA signif-
icantly decreased it (P = 0.016) when compared to control (Fig. 4E), showing a non-monotonic dose-response 
curve. This is consistent with previous results obtained in vivo where increased ductal development was observed 
in fetuses of dams exposed to low BPA doses28. The number of ductal tips was significantly decreased in explants 
exposed to 1 μ M BPA (P = 0.012) when compared to control (Fig. 4E).
Role of ER and GPER stromal receptors in the effect of E2 and BPA on ductal development. 
Among estrogen ligands, only ERα and β 28,35 and G protein-coupled estrogen receptor 1 (GPER)27 are 
expressed in the mesenchyme of the fetal mammary gland; they are not detected in the epithelium at this 
developmental stage. The effect of BPA was reversed by Fulvestrant (Ful), a nuclear ER antagonist36 (Fig. 4D 
and F). The ductal area of cultured mammary glands exposed to BPA + Ful was significantly smaller than that 
of glands treated with BPA alone (P = 0.013) (Fig. 4F). On the contrary, the effect observed with E2 was not 
reversed by treatment with Ful (Fig. 3D and F). The ductal area and number of ductal tips of mammary glands 
Figure 1. Comparison between CD-1 mouse fetal mammary glands grown in situ and in culture. Whole 
mounts of (A) E14 mammary glands, (B) glands cultured ex vivo in CDFBS for 5 days, (C) in situ embryonic 
mammary glands at E18 and (D) in situ embryonic mammary glands at E19. Arrows point to mammary buds. 
Scale bar: 200 μ m. Morphometric analysis comparing fetal mammary gland development in vivo with cultured 
explants. Graphs show (E) area of ductal growth and (F) number of ductal tips. Asterisk denotes significance. 
Data from three independent experiments, n = 25 and 21 for CDFBS and FBS cultured mammary glands, 
respectively; n = 39 for E18 and n = 5 for E19, shown for comparison.
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treated with E2 + Ful was similar to that of E2 alone (Fig. 3F). The ductal area and number of ductal tips of 
the cultured mammary glands exposed to E2 + G-15, a GPER antagonist, were not significantly different from 
those exposed to E2 alone (Fig. 3F).
Discussion
Fetal exposure to xenoestrogens has long-term consequences regarding the risk of developing breast cancer 
during adult life37. For example, fetal exposure to the pesticide dichloro-diphenyl-trichloroethane (DDT)38 and 
diethylstilbestrol (DES) results in a higher risk of developing breast cancer than in unexposed women2. Similarly, 
exposure to the environmental estrogen BPA, a compound structurally related to DES, has been shown to induce 
intraductal hyperplasias, ductal carcinoma in situ (DCIS) and palpable tumors in rodents7–12,39. Early life expo-
sure to these estrogenic compounds is associated with the risk of developing breast cancer later in life; however 
the gap of several decades that exists between the time of exposure and that of the clinical detection of neoplasia 
makes it difficult to identify the chain of events that lead to breast cancer. In addition to the indirect effect of these 
estrogens on the HPOA, we have hypothesized that those initial causal events occur through a direct action of 
the estrogenic compounds on mammary gland morphogenesis4. In this regard, using our culture method, we 
found that environmentally relevant doses of BPA increased ductal development in a comparable manner to that 
observed in the fetal mammary glands of mice and primates exposed in utero28,29, whereas high doses inhibited it.
In utero exposure to natural estrogen has also been associated with an increased risk of developing breast 
cancer in twin pregnancies40 and a decreased risk associated with pre-eclampsia41. These correlations assume that 
two placentas represent higher estrogen exposure than a single one, and that pre-eclampsia is a marker of low 
estrogen levels. Due to the impossibility of removing estrogens during pregnancy, there is a lack of experimental 
evidence of the action of E2 on the fetal mammary gland. Reports in the literature regarding the effect of exoge-
nous E2 on the developing mammary gland used supra-physiological doses. One examined E18 mammary glands 
of female mice embryos injected in utero and found inhibition of mammary development beyond the bud stage42. 
Another report, now in humans, showed that still-born fetuses whose mothers were treated with estrogen and 
progesterone during early pregnancy also exhibited inhibition of mammary gland development43. In contrast, by 
exposing the explants to physiological levels of estradiol we found that these levels do not arrest mammary gland 
development at the bud stage; instead, it resulted in the development of an epithelial tree smaller than that of the 
unexposed control.
We have also gained insight into how BPA and E2 affect the fetal mammary gland. The effect of BPA was 
inhibited by the antiestrogen Ful suggesting that BPA is acting through nuclear ERs present in the stroma27,28,44. 
In contrast, the effect of E2 was not inhibited by Ful, suggesting that at this early stage of development E2 could 
be acting through an alternative pathway. By revealing functional differences between the effect of E2 and BPA, 
our findings illustrate the complexity of hormone regulation in target organs. This complexity was also reflected 
by the gene expression pattern of fetal mammary glands exposed to different estrogens. The gene expression pat-
tern of the stroma of BPA- exposed animals mostly overlapped with that of the stroma exposed to the steroidal 
estrogen ethinyl estradiol. However, the patterns were not identical, showing a set of genes that were differen-
tially regulated by each one of these estrogens27. A comparable result was obtained when using estrogen-sensitive 
MCF7 cells45. In addition to gene expression end points, functional differences between BPA and estradiol have 
also been reported in the brain where E2 causes a rapid stimulatory action in luteinizing hormone-releasing 
hormone neurons and this effect is not blocked by Ful46,47; this suggests that the action of E2 is independent of ER 
and in fact it appears to be mediated by GPER48. We initially hypothesized that E2 could be acting through GPER 
present in the stroma of the fetal mammary gland27. The effect of E2 was not reversed by treatment with G-15, a 
GPER antagonist. However, the role of GPER cannot be excluded at this point due to the variability observed in 
the mammary explants treated with G-15. The use of the ex vivo culture system presented herein will allow us to 
Figure 2. Development of the epithelium in cultured ex vivo mammary glands. (A) Confocal projection of 
a fetal mammary gland cultured ex vivo for 5 days. Scale bar: 100 μ m. (B) and (C) Inset boxes from panel A are 
optical sections showing lumen. (D) Ductal tip of a cultured mammary gland shows expression of K8 (red) and 
K14 (green); arrowhead points to K8+ /K14+ cells. Scale bar: 20 μ m.
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Figure 3. Effect of E2 on fetal mammary glands cultured ex vivo. Carmine stained whole mounts of cultured 
mammary explants in (A) Control (CDFBS), (B) 1 nM E2, (C) 10 pM E2 and (D) 10 pM E2 + 10 nM Ful. Scale 
bar: 200 μ m. (E) Ductal area and number of ductal tips of mammary buds treated with E2 compared to control. 
Asterisk denotes significance compared with control. Data from three independent experiments, n = 18 for area 
and n = 17 for number of ductal tips in control, n = 9 in 1 fM, n = 14 for area and n = 15 for number of ductal 
tips in 0.1 pM, n = 9 for area and n = 10 for number of ductal tips in 10 pM and n = 16 in 1 nM group. (F) Effect 
of Ful (10 nM) and G-15 (1 nM) on E2 (10 pM) -treated mammary bud cultures. Data from three independent 
experiments, n = 21 for area and n = 20 for number of ductal tips in E2, n = 17 for area and n = 16 for number 
of ductal tips in Ful, n = 12 for area and n = 11 for number of ductal tips in G-15, n = 19 for area and n = 18 for 
number of ductal tips in E2 + Ful and n = 9 in E2 + G15.
Figure 4. Effect of BPA on fetal mammary glands cultured ex vivo. Carmine stained whole mounts 
of cultured mammary explants in (A) Control (CDFBS), (B) 1 nM BPA, (C) 1 μ M BPA and (D) 1 nM 
BPA + 100 nM Ful. Scale bar: 200 μ m. (E) Ductal area and number of ductal tips of mammary buds treated with 
BPA compared to control. Asterisk denotes significance compared with control. Data from three independent 
experiments, n = 22 for area and n = 21 for number of ductal tips in control, n = 12 in 0.1 nM, n = 20 in 1 nM 
and n = 8 for area and n = 9 for number of ductal tips in 1 μ M group. (F) Effect of Ful (100 nM) on BPA (1 nM) 
-treated mammary bud cultures. Asterisk denotes a statistically significant difference from BPA alone. Data 
from three independent experiments, n = 9 for area and n = 8 for number of ductal tips in BPA and in Ful and 
n = 10 in BPA + Ful.
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further explore the manner by which E2 inhibits ductal growth, for example by using specific antagonists for ERα 
and ERβ and receptor null mutants.
Finally, the ex vivo explant culture and the morphological measurements described herein as indicators of 
altered mammary gland development could be used as reliable tools to assess compounds for their likelihood to 
contribute to altered mammogenesis, which in turn is a prerequisite for neoplasia.
Conclusion
By using a unique ex vivo culture assay that circumvents the impossibility of removing estrogens from the 
feto-maternal unit, we show that natural and environmental estrogens directly alter fetal mammary gland 
development. The alterations observed occur within physiological levels of estradiol and of environmental BPA 
exposure. Additionally, this ex vivo culture assay makes it possible to examine the developmental toxicity of envi-
ronmental chemicals suspected to cause breast cancer. This study also provides further insight into a) the role of 
estrogens and xenoestrogens on breast carcinogenesis, and b) the action of hormones on normal mammary gland 
development.
Materials and Methods
Dissection and culture of CD-1 fetal mammary glands. CD-1 mice were purchased from Charles 
River and maintained at the Tufts University School of Medicine animal facility. All animal procedures were 
approved by the Tufts University and Tufts Medical Center Institutional Animal Care and Use Committee 
(Animal Welfare Assurance no. A3775-01, protocol number B2013-138) in accordance with the Guide for Care 
and Use of Laboratory Animals. The methods carried out in this work are in accordance with approved guide-
lines. CD-1 mice were mated and females were checked for the presence of vaginal plugs. The morning that 
the vaginal plug was observed was considered E1. Fetuses were removed from the pregnant mouse at E14. The 
mammary buds of female embryos were dissected and cultured following the technique described by Voutilainen 
et al.31,32. The mammary explant typically contained mammary buds #2, 3, and 4. Culture media was phenol red 
free-DMEM/F12 supplemented with 2 mM L-glutamine, 10% CDFBS (except for cultures using FBS), 75 μ g/ml 
ascorbic acid and penicillin/streptomycin (base media). For details on CDFBS procedures and filter membranes 
see Supporting Information. Explants were cultured for 5 days and culture media was changed twice during the 
culture period. Mammary gland development can be followed by phase-contrast microscopy (Fig. S1). After har-
vest, explants were left on filters during further processing. A detailed protocol of tissue dissection and culture is 
provided as Supporting Information.
BPA, E2, Fulvestrant and G-15 treatments. E2 was dissolved in ethanol to obtain a 1 mM stock solu-
tion. BPA, Fulvestrant (ICI 182,780) and G-15 were dissolved in DMSO to obtain a 1 mM, 10 mM and 50 mM 
stock solution, respectively. Fulvestrant was used at 10 and 100 nM. G-15 was used at 1 nM. Stocks were diluted 
in base medium as described above to final concentrations. Control explants were cultured in base medium 
alone.
Sample processing for whole mounts. On day 5 of culture, the explants were fixed in 10% paraformal-
dehyde and processed for carmine staining32. After carmine staining, explants were dehydrated using a series of 
ethanol dilutions (25, 50, 70 and 100%) and xylene. The explants were then whole-mounted on glass slides using 
permount.
Morphometric analysis. Whole mounted explants were viewed through a Zeiss Stemi 2000-c dissection 
scope at 5x. Images were captured by an AxioCam HRc digital camera (Zeiss) and processed with Axiovision 
software (version 4.3; Zeiss). The area of the ductal growth was measured by outlining the ducts using the outline 
spline feature and ductal tips were counted. The most developed mammary bud in each explant according to area 
of ductal growth was included in the analysis. Whole mounted fourth inguinal mammary glands of E18 and E19 
female CD-1 mice were imaged and measured as described for the whole mounted explants.
Immunofluorescence staining on whole-mounts. Explants were harvested and transferred to wells of 
a 24-well plate. The protocol for immunostaining was adapted from Kogata N & Howard BA44. Briefly, explants 
were fixed in 4% paraformaldehyde for 1 h, blocked and permeabilized for 1 h at room temperature. The explants 
were incubated with primary antibodies overnight and then with secondary antibodies for 4 h at 4 °C. Primary 
antibodies used were cytokeratins (K) 8 (rat, 1:100) (Troma-I, Developmental Studies Hybridoma Bank) and K14 
(rabbit, 1:200) (RB-9020, Thermo Fisher). The secondary antibodies (1:1000) used were Cy2-conjugated donkey 
anti-rat and RRX-conjugated donkey anti-rabbit (Jackson Immunoresearch). Images were acquired using a Zeiss 
LSM510 confocal microscope.
Statistical analysis. SPSS software package 15.0 (SPSS) was used for all statistical analyses. The analysis was 
performed on data after mathematical outliers (values that fell below or above more than 2 SD from the mean) 
were removed. T-tests were used to compare i) the growth of cultured mammary glands with E18 mammary 
glands; ii) cultures exposed to E2, with E2 + G-15 and E2 + Ful, and iii) cultures exposed to BPA with BPA + Ful. 
One-way ANOVA and Bonferroni’s post hoc test was used to assess differences between controls and cultures 
exposed to different concentrations of E2 and BPA. For all statistical tests, results were considered significant at 
P < 0.05. All results are presented as mean ± SEM; n value reported applies to both ductal area and number of tips 
unless otherwise stated.
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